BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33190256)

  • 1. Improvements in outcome of childhood acute lymphoblastic leukaemia (ALL) in the UK - a success story of modern medicine through successive UKALL trials and international collaboration.
    Bartram J; Veys P; Vora A
    Br J Haematol; 2020 Nov; 191(4):562-567. PubMed ID: 33190256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of being underweight and overweight and obesity at diagnosis in UK patients with childhood acute lymphoblastic leukaemia 1985-2002.
    Aldhafiri FK; McColl JH; Reilly JJ
    J Hum Nutr Diet; 2014 Feb; 27(1):76-9. PubMed ID: 23781853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey C; Richards SM
    Lancet; 1995 Jan; 345(8943):143-8. PubMed ID: 7823668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome.
    Lashkari HP; Faheem M; Sridevi Hanaganahalli B; Bhat KG; Joshi J; Kamath N; Ahlawat S; B P
    Expert Rev Hematol; 2020 Oct; 13(10):1143-1151. PubMed ID: 32870048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
    Hann I; Vora A; Richards S; Hill F; Gibson B; Lilleyman J; Kinsey S; Mitchell C; Eden OB
    Leukemia; 2000 Mar; 14(3):356-63. PubMed ID: 10720126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
    Chessells JM; Richards SM; Bailey CC; Lilleyman JS; Eden OB
    Br J Haematol; 1995 Feb; 89(2):364-72. PubMed ID: 7873387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
    Chessells JM; Harrison G; Richards SM; Gibson BE; Bailey CC; Hill FG; Hann IM;
    Br J Haematol; 2002 Aug; 118(2):445-55. PubMed ID: 12139731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoblastic leukemia: optimizing treatment strategies in children.
    Vora A
    Paediatr Drugs; 2002; 4(6):405-16. PubMed ID: 12038876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival after childhood acute lymphoblastic leukaemia: population-based trends in cure and relapse by clinical characteristics.
    Smith L; Glaser AW; Kinsey SE; Greenwood DC; Chilton L; Moorman AV; Feltbower RG
    Br J Haematol; 2018 Sep; 182(6):851-858. PubMed ID: 29808915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    Eden OB; Lilleyman JS; Richards S; Shaw MP; Peto J
    Br J Haematol; 1991 Jun; 78(2):187-96. PubMed ID: 2064956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALL.
    Fielding AK; Goldstone AH
    Br J Haematol; 2020 Nov; 191(4):558-561. PubMed ID: 33190258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
    Wheeler K; Richards S; Bailey C; Chessells J
    Br J Haematol; 1998 Apr; 101(1):94-103. PubMed ID: 9576189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Medical Research Council trials in adult acute lymphocytic leukemia.
    Durrant IJ; Richards SM; Prentice HG; Goldstone AH
    Hematol Oncol Clin North Am; 2000 Dec; 14(6):1327-52. PubMed ID: 11147226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
    Hargrave DR; Hann II; Richards SM; Hill FG; Lilleyman JS; Kinsey S; Bailey CC; Chessells JM; Mitchell C; Eden OB;
    Br J Haematol; 2001 Feb; 112(2):293-9. PubMed ID: 11167821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey CC; Richards S
    Leukemia; 1992; 6 Suppl 2():157-61. PubMed ID: 1578921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
    Chessels JM; Swansbury GJ; Reeves B; Bailey CC; Richards SM
    Br J Haematol; 1997 Oct; 99(1):93-100. PubMed ID: 9359508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003.
    Bartram J; Wade R; Vora A; Hancock J; Mitchell C; Kinsey S; Steward C; Moppett J; Goulden N
    Arch Dis Child; 2016 May; 101(5):449-54. PubMed ID: 26865705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia.
    Morris EC; Harrison G; Bailey CC; Hann IM; Hill FG; Gibson BE; Richards S; Webb DK;
    Br J Haematol; 2003 Mar; 120(5):787-9. PubMed ID: 12614210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
    Lawson SE; Harrison G; Richards S; Oakhill A; Stevens R; Eden OB; Darbyshire PJ
    Br J Haematol; 2000 Mar; 108(3):531-43. PubMed ID: 10759711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Eden OB; Bailey CC; Lilleyman JS; Richards SM
    Leukemia; 1994 Aug; 8(8):1275-9. PubMed ID: 8057661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.